Advertisement
UK markets close in 3 hours 36 minutes

  • FTSE 100

    8,048.70
    +24.83 (+0.31%)
     

  • FTSE 250

    19,713.14
    +113.75 (+0.58%)
     

  • AIM

    753.45
    +4.27 (+0.57%)
     

  • GBP/EUR

    1.1605
    +0.0016 (+0.14%)
     

  • GBP/USD

    1.2385
    +0.0034 (+0.28%)
     

  • Bitcoin GBP

    53,292.89
    +97.86 (+0.18%)
     

  • CMC Crypto 200

    1,419.92
    +5.16 (+0.36%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    81.36
    -0.54 (-0.66%)
     

  • GOLD FUTURES

    2,315.70
    -30.70 (-1.31%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    18,041.99
    +181.19 (+1.01%)
     

  • CAC 40

    8,085.99
    +45.63 (+0.57%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Orion Corporation: Managers’ transactions – Olli Huotari

Orion Oyj
·1-min read
Orion Oyj
Orion Oyj

ORION CORPORATION
MANAGERS’ TRANSACTIONS
2 MARCH 2023 at 15.00 EET

Orion Corporation: Managers’ transactions – Olli Huotari

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Olli Huotari
Position: Other senior manager

Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 26365/5/4

ADVERTISEMENT

____________________________________________
Transaction date: 2023-03-01
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 8000 Unit price: 0 EUR

Aggregated transactions (1):
Volume: 8000 Volume weighted average price: 0 EUR

Orion Corporation

Liisa Hurme

President and CEO

   

Olli Huotari

SVP, Corporate Functions

 

                                                

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.